CHAD Therapeutics Income Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Mar 08 | Mar 07 | Mar 06 | |
|---|---|---|---|
| Revenue | 0.0 | 19.0 | 22.4 |
| Cost of Goods Sold | -- | 13.7 | 15.1 |
| Gross Profit | -- | 5.3 | 7.2 |
| Gross Profit Margin | 0.0% | 27.9% | 32.4% |
| SG&A Expense | 2.3 | 7.4 | 7.9 |
| Depreciation & Amortization | 0.7 | 0.4 | 0.5 |
| Operating Income | (3.1) | (2.5) | (1.1) |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | 0.0 | 0.1 | 0.0 |
| Nonoperating Expenses | 1.5 | -- | -- |
| Income Before Taxes | (4.5) | (2.4) | (1.1) |
| Income Taxes | 0.0 | 1.0 | (0.4) |
| Net Income After Taxes | (4.5) | (3.4) | (0.7) |
| Continuing Operations | (4.5) | (3.4) | (0.7) |
| Discontinued Operations | (4.1) | -- | -- |
| Total Operations | (8.6) | (3.4) | (0.7) |
| Total Net Income | (8.6) | (3.4) | (0.7) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | 0.85 | (0.34) | (0.07) |
| Dividends per Share | -- | -- | -- |
This data is provided as per license from EDGAR Online
